Biovica International AB (publ) 9II.F Stock
Biovica International AB (publ) Price Chart
Biovica International AB (publ) 9II.F Financial and Trading Overview
| Biovica International AB (publ) stock price | 0.11 EUR |
| Previous Close | 0.53 EUR |
| Open | 0.52 EUR |
| Bid | 0.59 EUR x N/A |
| Ask | 0.64 EUR x N/A |
| Day's Range | 0.52 - 0.52 EUR |
| 52 Week Range | 0.52 - 3.85 EUR |
| Volume | 3.75K EUR |
| Avg. Volume | 66 EUR |
| Market Cap | 23.5M EUR |
| Beta (5Y Monthly) | 0.986206 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.22 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
9II.F Valuation Measures
| Enterprise Value | 24.06M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.07232617 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Biovica International AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.986206 |
| 52-Week Change | -82.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.85 EUR |
| 52 Week Low | 0.52 EUR |
| 50-Day Moving Average | 0.62 EUR |
| 200-Day Moving Average | 0.97 EUR |
9II.F Share Statistics
| Avg. Volume (3 month) | 66 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 39.47M |
| Float | 32.14M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 1.00% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | April 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 87.38% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.20% |
| Return on Equity (ttm) | -57.51% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 73.40% |
| Gross Profit (ttm) | 4.73M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 6.29 EUR |
| Current Ratio (mrq) | 8.423 |
| Book Value Per Share (mrq) | 7.162 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Biovica International AB (publ)
| Country | Germany |
| State | N/A |
| City | Uppsala |
| Address | Dag HammarskjOelds vAeg 54B |
| ZIP | 752 37 |
| Phone | 46 1 84 44 48 30 |
| Website | https://www.biovica.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 33 |
Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood serum or cell cultures. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.
Q&A For Biovica International AB (publ) Stock
What is a current 9II.F stock price?
Biovica International AB (publ) 9II.F stock price today per share is 0.11 EUR.
How to purchase Biovica International AB (publ) stock?
You can buy 9II.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biovica International AB (publ)?
The stock symbol or ticker of Biovica International AB (publ) is 9II.F.
Which industry does the Biovica International AB (publ) company belong to?
The Biovica International AB (publ) industry is Biotechnology.
How many shares does Biovica International AB (publ) have in circulation?
The max supply of Biovica International AB (publ) shares is 107.94M.
What is Biovica International AB (publ) Price to Earnings Ratio (PE Ratio)?
Biovica International AB (publ) PE Ratio is now.
What was Biovica International AB (publ) earnings per share over the trailing 12 months (TTM)?
Biovica International AB (publ) EPS is -0.22 EUR over the trailing 12 months.
Which sector does the Biovica International AB (publ) company belong to?
The Biovica International AB (publ) sector is Healthcare.